BioStone Animal Health Launches Mycobacterium Bovis (M. Bovis) Antibody Test Kit
DALLAS-FORT WORTH, TX — October 17, 2022 — BioStone Animal Health is pleased to announce the launch of AsurDxTM Mycobacterium Bovis (M. Bovis) Antibody Test Kit for the detection of cattle antibodies specific to Mycobacterium bovis (M. bovis). Bovine tuberculosis is a chronic bacterial disease of animals caused by members of the Mycobacterium tuberculosis complex, primarily by M. bovis. It is a major zoonotic disease, and cattle are the main source of infection for humans. It also affects other domesticated animals such as sheep, goats, equines, pigs, dogs, and cats, and wildlife species such as wild boars, deer, and antelopes. The AsurDxTM Mycobacterium bovis (M. bovis) Antibody Test Kit provides a simple, rapid, sensitive, and cost-effective enzyme-based immunoassay (ELISA) screening method.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. BioStone strives to actively promote and participate in global animal health initiatives by making these test kits available to the international community. For more information about BioStone Animal Health, visit www.biostoneah.com